Alper Sismanoglu

Dr. Alper Sismanoglu

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Open access
PDF file
ASAlper Sismanoglu
Alper Sismanoglu
HTH. I. Tekin
H. I. Tekin
HEH. F. Erden
H. F. Erden
NCN. H. Ciray
N. H. Ciray
UUU. Ulug
U. Ulug
MBM. Bahceci
M. Bahceci
To compare fertilization, implantation and pregnancy rates in donor oocyte cycles triggered for final oocyte maturation with either human chorionic gonadotropin (hCG) or gonadotropin releasing hormone (GnRH) agonist in the same donor population in two sequential stimulation cycles. Prospective randomized cross-over trial. Private infertility clinic. Eighty-eight stimulation cycles in 44 egg donors. Controlled ovarian hyperstimulation (COH) with GnRH antagonist protocol triggered with hCG or GnRH agonist (leuprolide acetate 0.15 mg) in the same egg donors in two consecutive cycles. The primary outcome measure was the proportion of mature and fertilized oocytes per donor cycle. Secondary outcome measures were implantation and pregnancy rates in the recipients and incidence of ovarian hyperstimulation syndrome (OHSS) in oocyte donors. The proportion of mature oocytes, fertilized oocytes and mean embryo scores were comparable between the two triggering agents. While implantation (36.53% vs, 32.93%), pregnancy (69.08% vs. 68.81%) and clinical pregnancy (41.3% vs. 40.2%) rates were comparable for the groups, the incidence of OHSS was significantly lower in GnRH than in hCG triggered cycles. Fertilization, implantation and pregnancy rates from donor oocytes stimulated with GnRH antagonist protocol were identical for donor cycles triggered with hCG and GnRH agonist. GnRH antagonist triggering in egg donors was associated with lower rates of OHSS.

1 April 2020 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
ASAytek Sik
Aytek Sik
SOSerkan Oral
Serkan Oral
YAYılda Arzu Aba
Yılda Arzu Aba
OOOzan Ozolcay
Ozan Ozolcay
MKMehmet Koc
Mehmet Koc
ASAlper Sismanoglu
Alper Sismanoglu

Verified
Journal Article
Open access
PDF file
ASAlper Sismanoglu
Alper Sismanoglu
SOSüleyman Cemil Oğlak
Süleyman Cemil Oğlak
CÖCenk Özcan
Cenk Özcan
ulun ulugulun ulug
ulun ulug
Objective: Most studies concentrate on comparisons between the cleavage stage and blastocyst stage of embryos during in vitro stimulation treatment. We aimed, in this study, to compare the pregnancy rates of day 4 or day 5 blastocyst transfers, all derived from fresh, antagonist-regulated in vitro fertilization (IVF) cycles, and to evaluate the factors affecting pregnancy success. Methods: This retrospective cohort study evaluated 3681 fresh embryo transfer cycles conducted at a private IVF center between 2019 and 2021. Patients were divided into two groups based on the day of embryo transfer: day 4 (Group 1) and day 5 (Group 2). Subgroup analyses were performed according to age (≤40 vs. >40 years) and the number of oocytes retrieved (≤4 vs. >4). All patients underwent ovarian stimulation with FSH alone or in combination with hMG, and GnRH antagonist protocols were used for pituitary suppression. Final oocyte maturation was triggered with recombinant hCG, and fertilization was achieved via intracytoplasmic sperm injection (ICSI) for all cases. Embryos were cultured in sequential media and assessed daily until transfer on day 4 or day 5, based on embryo morphology and clinic logistics. Results: Pregnancy was more likely among women under 40 than among women over 40. There were a total of 1217 women who underwent day 4 transfer and 2464 women who underwent day 5 transfer. A total of 660 (54.2%) of the women transferred on day 4 developed pregnancy. Among those transferred on day 5, 1610 (65.3%) developed pregnancy. When compared to the 4th day, a single embryo transfer on the 5th day enhances pregnancy success by 1.8 times, while two embryo transfers raise it by 1.6 times. Furthermore, when the number of oocytes is greater than four and the number of embryos transferred is two, the pregnancy success rate is 2.5 times higher when embryo transfer is performed on the fifth day versus the fourth day. Regardless of age, oocyte count, or number of embryos transferred, 5th-day fresh embryo transfers enhanced pregnancy success by 1.9 times compared to 4th-day transfer. Conclusions: Transfers of fresh embryos on day 5 are superior to those on day 4 and should be favored, especially for people over the age of 40, regardless of the number of embryos transferred, even if that individual has fewer than four oocytes.

10 November 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
ASAlper Sismanoglu
Alper Sismanoglu
SOSüleyman Cemil Oğlak
Süleyman Cemil Oğlak
ZAZafer Atayurt
Zafer Atayurt
FSFulya gokdagli sagir
Fulya gokdagli sagir
ulun ulugulun ulug
ulun ulug
Background/Objectives: The timing of blastocyst formation is an important factor in in vitro fertilization (IVF) outcomes. While many studies have shown similar pregnancy rates for euploid blastocyst transfers occurring on day 5 or 6, controversy remains, especially regarding patients with recurrent implantation failure (RIF). This study aimed to evaluate whether day 5 (D5) and day 6 (D6) euploid blastocysts differ in terms of the clinical outcomes achieved after frozen–thawed euploid embryo transfer, with subgroup analysis by maternal age in RIF patients. Methods: This retrospective analysis included a cohort of 514 patients who experienced RIF, categorized into two distinct groups: the initial group consisting of individuals who underwent embryo biopsy on day 5 (n = 456 euploid transfers) and the subsequent group comprising patients who underwent biopsy on day 6 (n = 58 euploid transfers) following ovum retrieval. These groups were utilized based on the completion of blastocyst development and the eventual pregnancy outcomes after the first post-frozen–thawed euploid embryo transfer confirmed by PGT-A. Results: Out of the total cohort of 514 RIF patients, 472 individuals were younger than 40 years of age, representing 91.8% of the sample population. The IVF process yielded successful positive pregnancy outcomes in 85.4% of the cases (439 out of 514)., and there was no statistically significant difference in maternal ages between the day 5 and day 6 biopsy cohorts (p = 0.286). The proportion of successful clinical pregnancies per transfer was markedly higher among those who underwent biopsy on day 5 in comparison to those subjected to biopsy on day 6 (79.2% vs. 58.6%, p = 0.002). In patients aged 35 years and younger who underwent biopsy on day 5, the rates of successful clinical pregnancy outcomes were superior to those who underwent biopsy on day 6 (79.8% vs. 56.5% p = 0.016). In individuals older than 35 years of age, no significant discrepancies in clinical pregnancy rates were observed between the two groups. Conclusions: Day 6 euploid embryo transfer was associated with lower clinical pregnancy rates per transfer compared with those on day 5, particularly in patients younger than 35 years of age. In women ≥ 35 years of age, outcomes did not differ significantly. These outcomes suggest that developmental timing interacts with maternal age in determining clinical outcomes. Further prospective studies with larger and more balanced cohorts are needed to confirm these findings.

10 October 2022 in Research Square
Verified
Preprint
Open access
PDF file
SOSerkan Oral
Serkan Oral
ASAlper Sismanoglu
Alper Sismanoglu
Background This study aims compare the pregnancy and live birth rates between the oocytes retrieved without follicular flushing FF(-) in the oocyte pick-up (OPU) procedure performed in women with diminished ovarian reserve (DOR) and those retrieved by follicular flushing FF(+). Results The study was conducted among patients diagnosed with DOR according to Bologna criteria and applied to the clinic for IVF between 2017–2020. A total of 358 infertile women with follicles three and below on the hCG day, between the ages of 21 and 42, without severe male factor, without uterine anomaly, without uterine surgery, and who did not undergo PGD were included in the study. Each follicle was aspirated once in the OPU procedure, and if a follicle was retrieved, it was moved to the other follicle. If the follicle could not be retrieved, the oocyte was tried to be retrieved by flushing a maximum of 3 times. The number of oocytes retrieved, clinical pregnancy rate, and live birth rate were compared. Since all the oocytes retrieved in 143 patients were retrieved directly without the need for FF, it was named FF(-) group. Since at least one oocyte of the remaining 215 patients was retrieved by performing FF, it was named FF(+) group. Since some of the oocytes retrieved from 112 patients in the FF(+) group were retrieved with FF and some without FF, they were excluded from the study, and the remaining 103 cases formed the FF(+) group a total of 246 patients were compared. The mean number of MII oocytes ,the pregnancy rates, rates of live births and the abortion rates between two groups did not show any statistical difference. Conclusion FF applied during oocyte retrieval in DOR did not positively affect the number of retrieved oocytes, clinical pregnancy, and live birth rates even doing this may decrease the pregnancy rate because of the probable low quality egg but we should not forget that if we did not do flushing after once we aspirated the follicle we would not be able to obtain any pregnancy at all in this patients.